Control and Prevention of Bleeding Episodes
Helixate® FS is an antihemophilic factor that is indicated for the control and prevention of bleeding episodes in adults and children (0-16 years) with hemophilia A.
Helixate® FS is indicated for surgical prophylaxis in adults and children with hemophilia A.
Routine prophylaxis in Children with Hemophilia A with no Preexisting Joint Damage
Helixate® FS is indicated for routine prophylactic treatment to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no pre-existing joint damage.
*Helixate® FS is not indicated for the treatment of von Willebrand's disease.
For indications, dosing and other information, please refer to the prescribing information.